Related Experiment Videos
Novel furostanol glycosides from Allium macrostemon
1Department of Phytochemistry, Shenyang College of Pharmacy, People's Republic of China.
Planta Medica
|February 1, 1995
Summary
Two new furostanol saponins, macrostemonosides G and I, were isolated from Allium macrostemon Bunge. Macrostemonoside G demonstrated potential in inhibiting human platelet aggregation, suggesting therapeutic applications.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Pharmacology
Background:
- Allium macrostemon Bunge is a plant with traditional medicinal uses.
- Furostanol saponins are a class of natural compounds with diverse biological activities.
Purpose of the Study:
- To isolate and characterize new furostanol saponins from Allium macrostemon Bunge.
- To evaluate the preliminary pharmacological activity of the isolated compounds.
Main Methods:
- Preparative High-Performance Liquid Chromatography (HPLC) for isolation.
- Spectroscopic analyses including NMR (1H, 13C, COSY) and Mass Spectrometry (FAB-MS) for structural elucidation.
- In vitro assays to assess inhibition of adenosine diphosphate (ADP)-induced human platelet aggregation.
Main Results:
- Two new furostanol saponins, macrostemonosides G (1) and I (3), and an artifact, macrostemonoside H (2), were isolated.
- The structures of compounds 1, 2, and 3 were determined through extensive spectral data analysis.
- Macrostemonoside G (1) exhibited inhibitory activity against ADP-induced human platelet aggregation with an IC50 of 0.871 mM.
Conclusions:
- Allium macrostemon Bunge contains novel furostanol saponins with unique chemical structures.
- Macrostemonoside G shows promise as an antiplatelet agent, warranting further investigation for its therapeutic potential.